Piramal Life Sciences today said its net loss widened to Rs 40.97 crore in the fourth quarter ended March 31, 2011.
The company had posted a net loss of Rs 33.44 crore for the same period a year ago.
The company's net sales stood at Rs 69 lakh in the fourth quarter, compared to Rs 71 lakh in the same period last fiscal, Piramal Life Sciences said in a filing to the Bombay Stock Exchange (BSE).
For the year ended March 31, 2011, the company posted a net loss of Rs 142.98 crore, as against Rs 129.80 crore in the previous fiscal.
Net sales of the company for the year ended March 31, 2011, stood at Rs 15.90 crore, compared to Rs 6.21 crore in the previous fiscal.
Shares of Piramal Life Sciences were trading at Rs 100.80 on the BSE in the late afternoon today, down 6.01% from their previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app